Open | - |
Close | - |
Volume / Avg. | 301.000 / 1.386M |
Day Range | - - - |
52 Wk Range | 6.575 - 22.930 |
Market Cap | $1.177B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 12.94% |
Days to Cover | 6.2 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of 89bio (NASDAQ: ETNB) through any online brokerage.
Other companies in 89bio’s space includes: Immunome (NASDAQ:IMNM), Centessa Pharmaceuticals (NASDAQ:CNTA), Prothena Corp (NASDAQ:PRTA), Immatics (NASDAQ:IMTX) and Arcutis Biotherapeutics (NASDAQ:ARQT).
The latest price target for 89bio (NASDAQ: ETNB) was reported by HC Wainwright & Co. on Wednesday, March 13, 2024. The analyst firm set a price target for 31.00 expecting ETNB to rise to within 12 months (a possible 146.23% upside). 31 analyst firms have reported ratings in the last year.
The stock price for 89bio (NASDAQ: ETNB) is $12.59 last updated Today at March 19, 2024 at 8:33 AM EDT.
There are no upcoming dividends for 89bio.
89bio’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for 89bio.
89bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.